Label: BISMUSAL SUSPENSION- bismuth subsalicylate suspension
- NDC Code(s): 30798-931-35
- Packager: Durvet, Inc.
- Category: OTC ANIMAL DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated November 14, 2022
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- PURPOSE
- KEEP OUT OF REACH OF CHILDREN
- INDICATIONS:
- CAUTION:
- DOSAGE AND ADMINISTRATION:
- ACTIVE INGREDIENTS:
- WARNING:
- STORAGE:
- WHEN USING
- Net Contents:
- INFORMATION FOR OWNERS/CAREGIVERS
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
BISMUSAL SUSPENSION
bismuth subsalicylate suspensionProduct Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:30798-931 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (SALICYLIC ACID - UNII:O414PZ4LPZ) BISMUTH SUBSALICYLATE 17.4 g in 1 L Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:30798-931-35 4 in 1 CASE 1 3.785 L in 1 JUG Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 04/21/2015 Labeler - Durvet, Inc. (056387798) Establishment Name Address ID/FEI Business Operations FIRST PRIORITY INCORPORATED 179925722 manufacture, label, api manufacture